Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 8.9B | 11.5B | 9.1B | 10.4B |
Cost of revenue | 7.0B | 8.5B | 7.0B | 7.6B |
Gross profit | 1.9B | 3.0B | 2.1B | 2.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.1B | 1.4B | 1.2B | 1.2B |
Other operating expenses | -42M | 675M | -80M | -103M |
Operating income | 761M | 1.5B | 974M | 1.8B |
Non operating interest income | ||||
Income | — | 239M | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 747M | 1.2B | 891M | 1.8B |
Tax provision | 229M | 411M | 279M | 536M |
Net income | 518M | 831M | 611M | 1.2B |
Basic EPS | 0.6 | — | — | — |
Diluted EPS | 0.6 | — | — | — |
Basic average shares | 923.2M | — | — | — |
Diluted average shares | 923.2M | — | — | — |
EBITDA | 1.8B | 2.6B | 2.0B | 2.7B |
Net income from continuing op. | 747M | 1.2B | 891M | 1.8B |
Minority interests | -1M | -4M | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |